Listen To The Lancet Gastroenterology & Hepatology

In conversation with... Edouard Louis

Informações:

Synopsis

Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.